Articles tagged with Proliferative Responses
A new study reveals that RNA binding motif protein X-linked (RBMX) plays a crucial role in predicting cancer prognosis and response to immunotherapy. Abnormal expression of RBMX is associated with immune regulation, tumor microenvironment, and therapeutic effects of immune checkpoint inhibitors.
Scientists have developed a drug-eluting hydrogel that provides sustained, pH-dependent drug co-delivery and promotes anti-tumor immune responses, reducing tumor cell proliferation and growth. The treatment shows promise in treating hepatocellular carcinoma, with enhanced efficacy compared to traditional methods.
A recent study identifies a specific gene, GNL3, that regulates neural proliferation in response to lithium, which is used to treat bipolar disorder. This gene plays an important role in brain function and has been implicated in risk for bipolar disorder, schizophrenia, and inter-individual variations in intelligence.
Researchers discovered that the TERRA molecule, present at higher levels in ALT cancer cells, sets a damage threshold for these cells. Increasing TERRA levels causes DNA damage that is unsustainable for cancer cells, leading to their death.
Scientists from the University of Johannesburg found that shining two lasers on adult stem cells accelerates their transformation into different types of cells. The consecutive irradiation increases proliferation and differentiation under laboratory conditions, paving the way for potential therapies to repair damaged tissues.
Researchers found that certain human norovirus strains are more resistant to the body's natural defenses than others. This study highlights the importance of considering strain differences when studying norovirus biology and designing therapies.
Research in mice revealed that vaccination led to increased antigen-specific CD8+ T cell proliferation when administered mid-day. The circadian clock influences this response by controlling the cells' transcriptional program and modulating their responsiveness.
Mice treated with sonidegib exhibited significant taste bud and nerve response restoration within 14 days of discontinuing treatment. The study highlights the potential for recovery from severe taste loss following cancer drug treatment.
Researchers have identified a 'decoy' molecule that can modulate the body's immune response to the flu virus, reducing the risk of deadly inflammation. The molecule, 2R9, has shown promising results in mice, with only 22% dying from flu compared to 90% in untreated groups.
Rapid response teams dispatched to patients' rooms may be a quick fix rather than addressing deeper issues, according to Johns Hopkins patient safety expert Peter Pronovost. Better management of patient flow and staff schedules can help improve care for sickest patients.
Research found that IgA antibodies against HCV structural antigens are associated with necro-inflammatory activity, suggesting a potential marker for histological activity in chronic HCV infection. The study also revealed a broad and vigorous humoral response in chronic HCV infection, contrasting with weak cellular immune responses.
A functional link between new neuron production and antidepressant effectiveness has been discovered in an animal model. TrkB-mediated neural proliferation plays a crucial role in this mechanism, supporting the notion that impaired neurogenic niches contribute to refractory responses to antidepressive treatments.
Researchers discovered that estrogen receptor alpha (ERalpha) binds to a novel enhancer in the cyclin D1 gene (CCND1), promoting estrogen-responsive cell proliferation. This basic understanding may lead to the development of improved therapies for patients with breast cancer.
The study identifies six transcripts whose up- or down-regulation in rheumatoid arthritis (RA) parallels the changes seen in anergic cells. Calmodulin suppression in RA is consistent and dramatic, suggesting a link between anergic cells and disease-associated T cells.